Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Hairless gene not strongly linked to baldness.

Human head hair proteins can be typed into eight distinct patterns, useful for genetic and forensic investigations.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

More research is needed to improve wool and cashmere quality through genetics.

A genetic mutation in the SGK3 gene causes hairlessness in Scottish Deerhounds and may relate to human hair loss.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Neural networks can effectively predict hair loss.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

CRISPR-based tools improve understanding and treatment of skin development and conditions.

Inflammatory skin conditions are the most common in Brazilian children, with atopic dermatitis being the top issue.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

PCOS treatment should be personalized based on its type and the patient's reproductive goals.

Using trait prevalence priors in genetic prediction models for appearance traits is currently impractical due to limited knowledge and potential accuracy issues.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Hair diameter and curvature are mostly determined by genetics.